Why Nuclear’s Next Frontier Could Be 240,000 Miles Away
This year, nuclear energy stocks have been some of the market’s best performers. Small modular reactor (SMR) developers like NuScale Power (SMR) and Oklo (OKLO) have been announcing a steady stream of partnerships, and Donald Trump, has pushed fresh executive orders aimed at accelerating the sector’s development.
Investors have plenty of reason to be excited but a surprising new catalyst has emerged,
» Read more about: Why Nuclear’s Next Frontier Could Be 240,000 Miles Away »
Read More
This $11 Trillion Giant Just Got Cheaper, Is It Time to Buy?
When you manage more than $11 trillion in assets, your decisions ripple across global markets. That’s the world BlackRock (NYSE: BLK) operates in, a behemoth in asset management with tentacles in everything from ETFs and private equity to real estate and cutting-edge fintech. But in today’s choppy market, is BlackRock still a stock worth owning?
» Read more about: This $11 Trillion Giant Just Got Cheaper, Is It Time to Buy? »
Read More
Uber’s Stock Is Down But Business Is Booming, Why It Might Be a Buy
Uber (NYSE: UBER) has had its fair share of ups and downs lately. After peaking last October, the stock took a hit on the heels of Tesla’s flashy Cybercab announcement, a move that spooked investors and led to a sustained selloff into year-end.
While the stock has been slowly clawing its way back,
» Read more about: Uber’s Stock Is Down But Business Is Booming, Why It Might Be a Buy »
Read More
Can a Bitcoin ETF 30x Your Money?
If you’re bullish on Bitcoin but want more than just price appreciation, the MSTY ETF might be the most interesting option on the table.
MSTY (YieldMax MSTR Option Income Strategy ETF) is a covered call fund on MicroStrategy, a company whose stock is effectively a leveraged bet on Bitcoin.
Since launching in 2024,
» Read more about: Can a Bitcoin ETF 30x Your Money? »
Read More
This Move Might Reshape the Future of the Chip Industry
Lip-Bu Tan hasn’t been in the driver’s seat at Intel for long, but the new CEO is already making it clear that the era of open-ended spending is over. If Intel’s bleeding-edge chip manufacturing can’t justify its existence with real customer demand, it won’t get more money, period.
That kind of financial discipline might sound like corporate buzzkill,
» Read more about: This Move Might Reshape the Future of the Chip Industry »
Read MoreThe Burst
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Spotlight
Vanguard’s Hidden Opportunity in a Beaten-Down Sector
Vanguard is known for its low-cost, no-fuss ETFs and when it comes to equity investing, they offer a lineup of about 50 stock-focused funds that make it easy to diversify with a single ticker.
One of the more cyclical areas of the market is consumer discretionary and it’s been getting hit hard in 2025.
» Read more about: Vanguard’s Hidden Opportunity in a Beaten-Down Sector »
Read MoreThe Daily
Bullish Strengthens Fiat Rails Through Deutsche Bank Partnership
TLDR:
- Bullish secures Deutsche Bank partnership to expand fiat services for institutional crypto clients.
- The deal introduces API-enabled real-time reporting and faster payments for global Bullish users.
» Read more about: Bullish Strengthens Fiat Rails Through Deutsche Bank Partnership »